There are limited studies about cannabis hangovers. Cannabis hangovers happen frequently, but they often have the same feeling as an alcohol related hangover. There are limited scientific papers on the subject. However, there are a few facts that provide a partial understanding about what they are and how they happen. Yet, we do know what […]

Many cannabis consumers have experienced the infamous red eye. The eyes are often the most common giveaway after a serious session with a vaporizer. But how does cannabis affect overall eye health? Yet, while some may find the herb’s visible effects on the eyes to be burdensome, there are several surprising ways that cannabis supports […]

Australia’s Office of Drug Control has issued medical cannabis research licenses to two firms allowing them to cultivate and manufacture products for medical studies. The licenses were awarded to Canndeo LTD., a wholly-owned subsidiary of The Hydroponics Company (THC); and to a partnership between AusCann and Tasmanian Alkaloids. According to a report from the Examiner, […]

Veritas Pharma Inc. (CSE: VRT, OTCQB: VRTHF, Forum) announced yesterday that it will be sending a research team overseas next week to conduct research on licensed medical cannabis producers and clinical research organizations. The study will be conducted by the Company’s research arm, Cannevert Therapeutics Ltd. The purpose of the research is to identify potential […]

The Hydroponics Company (ASX:THC) is one of the first ASX-listed cannabis companies to have secured a medicinal cannabis research licence. The license was granted to THC’s wholly owned subsidiary Canndeo Ltd by the Office of Drug Control. The research licence will allow Canndeo to build its exclusive Plant Breeders Rights (PBR) protected Cannabis sativa strains. […]

July 11 Hydroponics Company Ltd * Medicinal cannabis research licence granted * Hydroponics company says office of drug control has issued Canndeo Limited, a wholly owned subsidiary of co, with a cannabis research licence Source text for Eikon: Further company coverage: … read more at:

Blackheads? Zits? Say goodbye to acne with a brand new cure—synthetic cannabis! That, at least, is the hope of Botanix Pharmaceuticals Ltd., a dermatological company that just announced the completion of its Phase 1 clinical trial for an acne drug that incorporates synthetic cannabidiol (CBD). Called BTX 1503, the goal is that the drug could […]